<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00004326</url>
  </required_header>
  <id_info>
    <org_study_id>199/11872</org_study_id>
    <secondary_id>UMMC-1043</secondary_id>
    <nct_id>NCT00004326</nct_id>
  </id_info>
  <brief_title>Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Center for Research Resources (NCRR)</source>
  <brief_summary>
    <textblock>
      OBJECTIVES: I. Evaluate whether chronic hypercortisolemia is specifically toxic to&#xD;
      hippocampal cells and causes structural reduction of hippocampal volume in patients with&#xD;
      Cushing's syndrome.&#xD;
&#xD;
      II. Determine whether reduced hippocampal volume is associated with specific memory&#xD;
      dysfunction.&#xD;
&#xD;
      III. Examine the relationships of adrenal androgen to hippocampal volume and memory&#xD;
      dysfunction.&#xD;
&#xD;
      IV. Examine the reversibility of hippocampal structural changes and cognitive dysfunction&#xD;
      after cortisol levels are normalized.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROTOCOL OUTLINE: Patients undergo a psychiatric evaluation for mood and cognition during&#xD;
      confirmation of diagnosis. Neuropsychologic exams include pencil and paper test and a&#xD;
      cognitive assessment.&#xD;
&#xD;
      Endocrine studies include dexamethasone and corticotropin-releasing hormone stimulation&#xD;
      tests. The hippocampal complex volume is assessed with coronal magnetic resonance imaging.&#xD;
&#xD;
      There is a follow-up 1 year after the initiation of treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 1994</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment>12</enrollment>
  <condition>Cushing's Syndrome</condition>
  <eligibility>
    <criteria>
      <textblock>
        PROTOCOL ENTRY CRITERIA:&#xD;
&#xD;
          -  Adults and teenagers with untreated, spontaneous active Cushing's syndrome&#xD;
&#xD;
          -  Diagnosis verified at the University of Michigan Medical Center, including the&#xD;
             following: Excessive cortisol secretion measured by urinary-free cortisol, cortisol&#xD;
             secretion rate, and plasma cortisol level&#xD;
&#xD;
          -  Lack of normal circadian cortisol secretion and failure to suppress following 2 mg of&#xD;
             dexamethasone&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Monica N. Starkman</last_name>
    <role>Study Chair</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan Health Systems</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2002</verification_date>
  <study_first_submitted>October 18, 1999</study_first_submitted>
  <study_first_submitted_qc>October 18, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 1999</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>Cushing's syndrome</keyword>
  <keyword>endocrine disorders</keyword>
  <keyword>rare disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cushing Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

